期刊文献+

TLR7激动剂Gardiquimod上调BxPC-3细胞中IL-15 mRNA表达

The agonist of TLR7 Gardiquimod up-regulates the expression of interleukin-15 in Bx PC-3 cells
下载PDF
导出
摘要 目的研究TLR7在胰腺癌Bx PC-3细胞中表达,并探讨TLR7激动剂激活TLR7后细胞因子白介素15(IL-15)的表达。方法通过Western blot和Real-time PCR分析TLR7在细胞内的表达水平;Bx PC-3细胞经过不同时间点Gardiquimod(3μg/ml)的处理后,Real-time PCR分析TLR7激活后IL-15 mRNA水平表达变化;Western blot分析Gardiquimod刺激细胞后,磷脂酰肌醇-3-激酶-蛋白质丝氨酸苏氨酸激酶(PI3K-AKT)信号通路的变化。结果 Western blot和Real-time PCR结果显示:与外周血单核细胞(PBMC)相比,TLR7在Bx PC-3中弱表达;Real-time PCR分析显示:Gardiquimod处理细胞后能刺激细胞中IL-15的表达;TLR7激动剂能够激活PI3K-AKT信号通路。结论 Gardiquimod激活TLR7后能够上调IL-15的表达,并且其激活与PI3KAKT信号途径相关。 Objective To investigate the expression of Toll-like receptor 7 ( TLR7 ) in pancreatic cancer BxPC-3 cells, and to explore the effect of TLR7 activation on the expression of interleukin-15(IL-15). Methods BxPC-3 cells were used to analyze the expression of TLR7 by Western blot and Real-time PCR. The cells were treated with Gardiquimod (3 μg/ml) at different times, the expression of IL-15 at mRNA level by Real-time PCR. Western blot was performed to analyze the phosphorylation level changes of phosphatidyl inositol kinase serine/threonine kinase (PI3K-AKT) protein in BxPC-3 cells stimulated by TLR7 ligand Gardiquimod. Results Western blot and Real-time PCR results showed that compared with peripheral blood mononuclear cells ( PBMC ) , TLR7 presented weak expression in BxPC-3 cells. Gardiquimod could increase the expression of IL-15 in BxPC-3 cells. TLR7 agonist could activate the PI3K-AKT signaling pathway. Conclusion Gardiquimod can up-regulate the expression of IL-15 and this effect can be associated with PI3K-AKT signaling pathway.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第1期1-4,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81271748)
关键词 TLR7 Gardiquimod IL-15 PI3K-AKT BXPC-3 TLR7 Gardiquimod interleukin-15 PI3K-AKT BxPC-3
  • 相关文献

参考文献2

二级参考文献13

  • 1Lund J, Alexopoulou L, Sato A, et al. Recognition of single- stranded RNA viruses by Toll-like receptor 7[ J]. Proc Natl Aead Sci U S A,2004,101 (15) :5598 -603.
  • 2Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance [ J ]. Cancer Res,2005,65(12) :5009 -14.
  • 3Meyer T, Stoekfleth E. Clinical investigations of Toll - like reeep- tors agonists [ J ]. Expert Opin Investig Drugs,2008,17 (7) : 1051 - 65.
  • 4Sehǒn M P, Schǒn M. TLR7 and TLR8 as targets in cancer thera- py [ J ]. Oncogene, 2008,27 ( 2 ) : 190 - 9.
  • 5Sehgal G, Hua J, Bernhard E J, et al. Requirement for matrix metalloprteinase-9 (galatinase B) expression in metastasis by mu- fine protatecarcinoma[ J]. Am J Patho,1998,152(2) :591 -6.
  • 6Hamon B, Hamon P, Bovier-Lapierre M, et al. A child with resist- ance to thyroid hormone without thyroid hormone receptor genemutation : a 20-year follow up [ J ]. Thyroid, 2008,18 ( 1 ) : 35 - 44.
  • 7Branca M, Ciotti M, Santini D, et al. Activation of the ERK/ MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer [J]. Am J Clin Pathol,2004,122 (6) :902 - 11.
  • 8Albanell J, Codony-Servat J, Rojo F, et al. Activated extracellu- lar signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments [ J ]. Cancer Res, 2001,61 (17) :6500 - 10.
  • 9吴凤娟,Diwa Koirala,刘斯婕,金辄,胡春,李大伟.新型噻唑并三嗪类化合物R001抑制ERK1/2磷酸化的抗肿瘤作用[J].现代生物医学进展,2012,12(29):5638-5642. 被引量:9
  • 10王琦,梁涛,张更棉,苗菊香,李文涛.胃癌中ERK-1、VEGF的表达及相关性分析[J].西部医学,2013,25(2):230-231. 被引量:9

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部